HK1117737A1 - Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne - Google Patents

Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne

Info

Publication number: HK1117737A1
Authority: HK; Hong Kong
Prior art keywords: methoxydi; adamantyl; acne; treatment; propenoic acid
Prior art date: 2005-05-20

Application number

HK08108517.9A

Other languages

English (en)

Inventor

Claudio Pisano

Loredana Vesci

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-20

Filing date

2008-08-01

Publication date

2009-01-23

2008-08-01 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

2009-01-23 Publication of HK1117737A1 publication Critical patent/HK1117737A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Birds (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)

HK08108517.9A 2005-05-20 2008-08-01 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne HK1117737A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT000248A ITRM20050248A1 (it)	2005-05-20	2005-05-20	Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee.
PCT/EP2006/062088 WO2006122883A1 (en)	2005-05-20	2006-05-05	Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne

Publications (1)

Publication Number	Publication Date
HK1117737A1 true HK1117737A1 (en)	2009-01-23

Family

ID=36646157

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK08108517.9A HK1117737A1 (en)	2005-05-20	2008-08-01	Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne

Country Status (14)

Country	Link
US (1)	US7635719B2 (xx)
EP (1)	EP1890671B1 (xx)
JP (1)	JP5072833B2 (xx)
KR (1)	KR101307910B1 (xx)
CN (1)	CN101180028B (xx)
AR (1)	AR054361A1 (xx)
AU (1)	AU2006248981B2 (xx)
BR (1)	BRPI0611289A2 (xx)
CA (1)	CA2606567A1 (xx)
HK (1)	HK1117737A1 (xx)
IT (1)	ITRM20050248A1 (xx)
MX (1)	MX2007014222A (xx)
TW (1)	TWI365753B (xx)
WO (1)	WO2006122883A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5109383B2 (ja) *	2007-01-31	2012-12-26	大正製薬株式会社	アダパレン含有外用剤組成物
JP2009137874A (ja) *	2007-12-05	2009-06-25	Authele:Kk	ビタミンＣ（Ａｓｃｏｒｂｉｃａｃｉｄ）を含有するレシチンゲルおよびその製造方法
TW201031402A (en) *	2008-12-24	2010-09-01	Sigma Tau Ind Farmaceuti	New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
EP3301085A1 (en) *	2016-09-29	2018-04-04	Biogem S.Ca.R.L.	Retinoid derivatives with antitumor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6071923A (en) *	1994-09-16	2000-06-06	Bar-Ilan University	Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
FR2752734B1 (fr) *	1996-09-02	1998-11-06	Cird Galderma	Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf
US5994330A (en) *	1998-11-09	1999-11-30	El Khoury; Georges F.	Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
ITRM20010464A1 (it)	2001-07-31	2003-01-31	Sigma Tau Ind Farmaceuti	Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
BRPI0307550B8 (pt) *	2002-03-12	2021-05-25	Galderma Res & Dev	composição farmacêutica em gel tópica, de adapaleno 0,3%

2005
- 2005-05-20 IT IT000248A patent/ITRM20050248A1/it unknown
2006
- 2006-05-03 TW TW095115754A patent/TWI365753B/zh not_active IP Right Cessation
- 2006-05-05 CN CN2006800175175A patent/CN101180028B/zh not_active Expired - Fee Related
- 2006-05-05 JP JP2008511670A patent/JP5072833B2/ja not_active Expired - Fee Related
- 2006-05-05 KR KR1020077027137A patent/KR101307910B1/ko not_active IP Right Cessation
- 2006-05-05 WO PCT/EP2006/062088 patent/WO2006122883A1/en not_active Application Discontinuation
- 2006-05-05 CA CA002606567A patent/CA2606567A1/en not_active Abandoned
- 2006-05-05 EP EP06755041.8A patent/EP1890671B1/en active Active
- 2006-05-05 US US11/911,749 patent/US7635719B2/en not_active Expired - Fee Related
- 2006-05-05 AU AU2006248981A patent/AU2006248981B2/en not_active Ceased
- 2006-05-05 BR BRPI0611289-7A patent/BRPI0611289A2/pt not_active IP Right Cessation
- 2006-05-05 MX MX2007014222A patent/MX2007014222A/es active IP Right Grant
- 2006-05-17 AR ARP060101983A patent/AR054361A1/es not_active Application Discontinuation
2008
- 2008-08-01 HK HK08108517.9A patent/HK1117737A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP5072833B2 (ja)	2012-11-14
US20080153916A1 (en)	2008-06-26
BRPI0611289A2 (pt)	2010-08-31
CA2606567A1 (en)	2006-11-23
KR101307910B1 (ko)	2013-09-16
TWI365753B (en)	2012-06-11
KR20080016573A (ko)	2008-02-21
US7635719B2 (en)	2009-12-22
ITRM20050248A1 (it)	2006-11-21
CN101180028B (zh)	2010-12-08
AR054361A1 (es)	2007-06-20
CN101180028A (zh)	2008-05-14
JP2008540603A (ja)	2008-11-20
EP1890671A1 (en)	2008-02-27
EP1890671B1 (en)	2014-03-05
WO2006122883A1 (en)	2006-11-23
AU2006248981B2 (en)	2011-06-02
WO2006122883A9 (en)	2012-10-04
TW200716192A (en)	2007-05-01
MX2007014222A (es)	2008-02-07
AU2006248981A1 (en)	2006-11-23

Publication	Publication Date	Title
PL1685834T3 (pl)	2009-09-30	Zastosowanie kwasu pinolenowego do leczenia otyłości
IL188331A0 (en)	2008-08-07	Method for the treatment of acne
PL2205273T3 (pl)	2017-09-29	Zastosowanie zmodyfikowanych komórek w leczeniu stwardnienia rozsianego
PT2056814E (pt)	2014-08-25	Compostos de 2,5-di-hidroxibenzeno para o tratamento da psoríase
IL185485A0 (en)	2008-08-07	Use of pde7 inhibitors for the treatment of neuropathic pain
IL208607A0 (en)	2010-12-30	Improved nanobodiestm for the treatment of aggregation-mediated disorders
EP1931344A4 (en)	2009-10-28	DEVICES FOR TREATING VESSELS
IL190920A0 (en)	2009-09-22	Compounds for the treatment of metabolic disorders
IL190913A0 (en)	2009-02-11	Methods for the treatment of hyperhidrosis
GB0908173D0 (en)	2009-06-24	Process for facilitating the management of care
ZA200709072B (en)	2008-11-26	Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
EP1968591A4 (en)	2010-02-17	TREATMENT OF SYNUCLEINOPATHIES
PT1945243E (pt)	2015-10-12	Utilização da calcitonina para o tratamento da ar
EP1888056A4 (en)	2008-09-03	USE OF LADOSTIGIL FOR TREATING MULTIPLE SCLEROSIS
GB0611240D0 (en)	2006-07-19	The treatment of increased sebum production
GB0611241D0 (en)	2006-07-19	The treatment of increased sebum production
ZA201100165B (en)	2011-09-28	Use of hdac inhibitors for the treatment of hodgkin's disease
HK1117737A1 (en)	2009-01-23	Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
PT1984005E (pt)	2011-07-11	Uso de complexos de gálio para o tratamento de melanomas
EP1732549A4 (en)	2009-11-11	METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES
GB0515138D0 (en)	2005-08-31	Acne treatment
IL191052A0 (en)	2008-12-29	Process for the preparation of tamsulosin and related compounds
GB0525540D0 (en)	2006-01-25	New treatment
ZA200706151B (en)	2009-09-30	Adapalene for the long-term treatment of acne vulgaris
ZA200606780B (en)	2008-08-27	Compounds for the treatment of diseases

Legal Events

Date	Code	Title	Description
2015-12-04	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20150505